Needham & Company Upgrades Esperion Therapeutics (ESPR) to Strong Buy; Shares Will Rebound

Go back to Needham & Company Upgrades Esperion Therapeutics (ESPR) to Strong Buy; Shares Will Rebound

Form 8-K Esperion Therapeutics, For: Aug 06

August 6, 2015 4:17 PM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

... More